Ignite Creation Date:
2024-05-06 @ 1:46 AM
Last Modification Date:
2024-10-26 @ 11:09 AM
Study NCT ID:
NCT01892345
Status:
TERMINATED
Last Update Posted:
2019-06-26
First Post:
2013-06-20
Brief Title:
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO PREVENT Study
Sponsor:
Organization:
Alexion Pharmaceuticals Inc